Department of Internal Medicine, Hunan Maternal and Child Health Hospital, Changsha, Hunan, 410013, China.
Department of Infection Control Center, Xiangya Hospital of Central South University, NO.87, Xiangya Road, Changsha, Hunan, 410008, China.
Ir J Med Sci. 2024 Apr;193(2):909-916. doi: 10.1007/s11845-023-03529-w. Epub 2023 Oct 12.
The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs.
This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs).
GSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis (n = 35), simple steatosis (n = 35), and NASH (n = 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR-582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro.
miR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients' plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers' expression but induced cell apoptosis, via TMBIM1.
This present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1.
肠道菌群失调与非酒精性脂肪性肝炎(NASH)相关,涉及 miRNA 的调节。
本研究旨在探讨非酒精性脂肪性肝炎(NASH)患者肠道微生物群与 miR-582-3p 的相关性,并探讨 miR-582-3p 对活化的肝星状细胞(HSCs)功能的可能调节作用。
通过 GEO2R 分析 GSE69670 和 GSE14435 数据集。从受试者中获取血浆和粪便样本,非脂肪变性(n=35)、单纯脂肪变性(n=35)和 NASH(n=35)。通过 16S rRNA 测序分析非脂肪变性和 NASH 组肠道微生物群的变化。采用 RT-qPCR 检测各组 miR-582-3p 的表达。采用 Pearson 相关系数分析 top 变化肠道微生物群与 miR-582-3p 表达之间的相关性。通过预测和双荧光素酶报告基因实验进行靶基因鉴定。在体外评估 miR-582-3p 对 TGF-β1 诱导的 HSCs 细胞功能的影响。
miR-582-3p 是 GSE69670 和 GSE14435 之间共同差异表达的 miRNA。NASH 患者血浆中以及 TGF-β1 诱导的 LX-2 细胞中 miR-582-3p 表达上调。非脂肪变性和 NASH 组肠道微生物群分布存在显著差异。miR-582-3p 与特定微生物群呈正相关。TMBIM1 是 miR-582-3p 的靶基因。敲低 miR-582-3p 通过 TMBIM1 抑制 HSC 增殖和肌成纤维细胞标志物的表达,但诱导细胞凋亡。
本研究表明,miR-582-3p 促进 NASH 的进展。敲低 miR-582-3p 通过改变肠道微生物群组成并调节 TMBIM1 可能缓解 NASH。